Carlsmed CARL
NASDAQ CARL
$15.60 +0.08 (+0.52%)
At close: Sep 4, 2026 · 4:00 PM EDT

Carlsmed (CARL) EBIT Growth (1y) (2025 - 2026)

Analysis

Carlsmed (CARL) EBIT Growth (1y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -17.50%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 30.74%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 22.08%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 49.06%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 43.83%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 24.81%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -95.55%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 49.72%
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn -1.28%
10 Carlsmed 424.72 Mn 311.42 Mn 14.54 Mn -69.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.73%
Mar 31, 2026 -62.20%
Dec 31, 2025 -98.38%
Sep 30, 2025 -16.18%
Jun 30, 2025 -2.90%